These guidelines recommend using unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), and, recently, direct factor Xa inhibitors for the prevention of VTE in cancer patients who are hospitalized [5–8]. Here, F10 is linked to cancer.